REGN stock · VRTX stock · Lician Pro · $19.99/mo or $149/yr
REGN vs VRTX · P/E 20, rev $14.34B vs P/E 30, rev $12.00B
Regeneron Pharmaceuticals Inc (REGN) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US. It is led by Leonard S. Schleifer M.D., Ph.D..
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US. It is led by Reshma Kewalramani FASN, M.D..
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 19.7.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.6.
REGN currently screens at market cap $59.10B and trailing P/E 19.7. VRTX currently screens at market cap $106.87B and trailing P/E 29.6.
Not investment advice. Open the REGN and VRTX stock pages for the full models.
Basic comparison
Price, market cap, and trailing P/E stay on this page.
| Metric | REGN | VRTX |
|---|---|---|
| Price | $796.44 | $508.75 |
| Market cap | $59.10B | $106.87B |
| Trailing P/E | 19.7 | 29.6 |
Deeper peer metrics
Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.
| Metric | REGN | VRTX |
|---|---|---|
| Net income | Pro | Pro |
| Revenue growth | Pro | Pro |
More peer metrics
Operating margin, EPS, free cash flow, and gross margin are on Pro.
REGN vs VRTX comparison FAQ
What is REGN's market cap?
Regeneron Pharmaceuticals Inc (REGN) currently screens at market cap $59.10B.
What is VRTX's market cap?
Vertex Pharmaceuticals Inc (VRTX) currently screens at market cap $106.87B.
What is REGN's P/E ratio?
Regeneron Pharmaceuticals Inc (REGN) screens at trailing P/E 19.7.
What is VRTX's P/E ratio?
Vertex Pharmaceuticals Inc (VRTX) screens at trailing P/E 29.6.
What is REGN's latest revenue?
Latest reported REGN revenue for 2025-12-31 was $14.34B.
What is VRTX's latest revenue?
Latest reported VRTX revenue for 2025-12-31 was $12.00B.
What is REGN's net income?
Net income was $4.50B for Regeneron Pharmaceuticals Inc (REGN).
Where is the REGN vs VRTX comparison listed?
The cached REGN vs VRTX comparison is listed at https://lician.com/compare/regn-vs-vrtx.
Not investment advice.